Related Experiment Videos
Multifactorial risk factor intervention in patients with Type 2 diabetes improves arginine bioavailability ratios
N J Tripolt1, A Meinitzer, M Eder
1Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria. norbert.tripolt@medunigraz.at
Summary
Intensified risk factor management improved arginine bioavailability ratios in Type 2 diabetes patients. This improvement was more significant in those with shorter diabetes duration, highlighting diabetes duration as a key factor.
Area of Science:
- Cardiovascular Health
- Metabolic Disorders
- Endothelial Function
Background:
- Endothelial dysfunction, marked by reduced nitric oxide bioavailability, is linked to cardiovascular risk.
- Arginine bioavailability ratios are emerging as potential cardiovascular outcome predictors in coronary artery disease.
- Type 2 diabetes is associated with endothelial dysfunction and increased cardiovascular risk.
Purpose of the Study:
- To assess the impact of multifactorial risk factor intervention on arginine bioavailability ratios in Type 2 diabetes patients.
- To evaluate global arginine bioavailability ratio and arginine to ornithine ratio as surrogate cardiovascular parameters.
- To investigate the influence of diabetes duration on the response to risk factor intervention.
Main Methods:
- Prospective, single-center study of 41 Type 2 diabetes patients with suboptimal glycemic, lipid, or blood pressure control.
- Intensified risk factor management implemented for 3 months according to current guidelines.
- Arginine, ornithine, and citrulline levels measured at baseline and 3 months via chromatography; ratios calculated.
Main Results:
- Multifactorial intervention significantly improved the global arginine bioavailability ratio (0.33 ± 0.12 to 0.38 ± 0.14, P = 0.018).
- Significant improvement observed in patients with diabetes duration < 5 years.
- No statistically significant improvement in arginine bioavailability ratio was noted in patients with longer diabetes duration.
Conclusions:
- Intensified risk factor management effectively enhances arginine bioavailability ratios in Type 2 diabetes.
- Diabetes duration is a critical factor affecting the improvement capacity of global arginine bioavailability ratio.
- Arginine bioavailability ratios may serve as valuable surrogate markers for cardiovascular risk in Type 2 diabetes management.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...